BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12893942)

  • 21. Cellular evidence for selfish spermatogonial selection in aged human testes.
    Maher GJ; Goriely A; Wilkie AO
    Andrology; 2014 May; 2(3):304-14. PubMed ID: 24357637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding the molecular basis of Apert syndrome.
    Ibrahimi OA; Chiu ES; McCarthy JG; Mohammadi M
    Plast Reconstr Surg; 2005 Jan; 115(1):264-70. PubMed ID: 15622262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vertebral anomalies and cartilaginous tracheal sleeve in three patients with Pfeiffer syndrome carrying the S351C FGFR2 mutation.
    Gonzales M; Heuertz S; Martinovic J; Delahaye S; Bazin A; Loget P; Pasquier L; Le Merrer M; Bonaventure J
    Clin Genet; 2005 Aug; 68(2):179-81. PubMed ID: 15996217
    [No Abstract]   [Full Text] [Related]  

  • 24. [Apert's syndrome: a case report].
    Doutetien C; Laleye A; Tchabi S; Biaou O; Lawani R; Deguenon J; Darboux R; Gnamey D; Bassabi SK
    J Fr Ophtalmol; 2003 Sep; 26(7):738-42. PubMed ID: 13130264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation.
    Lemonnier J; Delannoy P; Hott M; Lomri A; Modrowski D; Marie PJ
    Exp Cell Res; 2000 Apr; 256(1):158-67. PubMed ID: 10739663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormalities in cartilage and bone development in the Apert syndrome FGFR2(+/S252W) mouse.
    Wang Y; Xiao R; Yang F; Karim BO; Iacovelli AJ; Cai J; Lerner CP; Richtsmeier JT; Leszl JM; Hill CA; Yu K; Ornitz DM; Elisseeff J; Huso DL; Jabs EW
    Development; 2005 Aug; 132(15):3537-48. PubMed ID: 15975938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2.
    Jabs EW; Li X; Scott AF; Meyers G; Chen W; Eccles M; Mao JI; Charnas LR; Jackson CE; Jaye M
    Nat Genet; 1994 Nov; 8(3):275-9. PubMed ID: 7874170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pfeiffer's syndrome resulting from an S351C mutation in the fibroblast growth factor receptor-2 gene.
    Mathijssen IM; Vaandrager JM; Hoogeboom AJ; Hesseling-Janssen AL; van den Ouweland AM
    J Craniofac Surg; 1998 May; 9(3):207-9. PubMed ID: 9693549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FGFR2 mutations and acne.
    Rees J
    Lancet; 1998 Aug; 352(9129):668-9. PubMed ID: 9728976
    [No Abstract]   [Full Text] [Related]  

  • 30. A Crouzon syndrome synonymous mutation activates a 5' splice site within the IIIc exon of the FGFR2 gene.
    Del Gatto F; Breathnach R
    Genomics; 1995 Jun; 27(3):558-9. PubMed ID: 7558045
    [No Abstract]   [Full Text] [Related]  

  • 31. Pfeiffer syndrome type 2 associated with a single amino acid deletion in the FGFR2 gene.
    Priolo M; Lerone M; Baffico M; Baldi M; Ravazzolo R; Cama A; Capra V; Silengo M
    Clin Genet; 2000 Jul; 58(1):81-3. PubMed ID: 10945669
    [No Abstract]   [Full Text] [Related]  

  • 32. FGFs, their receptors, and human limb malformations: clinical and molecular correlations.
    Wilkie AO; Patey SJ; Kan SH; van den Ouweland AM; Hamel BC
    Am J Med Genet; 2002 Oct; 112(3):266-78. PubMed ID: 12357470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligand-independent activation of fibroblast growth factor receptor-2 by carboxyl terminal alterations.
    Lorenzi MV; Castagnino P; Chen Q; Chedid M; Miki T
    Oncogene; 1997 Aug; 15(7):817-26. PubMed ID: 9266968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A germ-line-selective advantage rather than an increased mutation rate can explain some unexpectedly common human disease mutations.
    Choi SK; Yoon SR; Calabrese P; Arnheim N
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10143-8. PubMed ID: 18632557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allelic loss at 10q26 in osteosarcoma in the region of the BUB3 and FGFR2 genes.
    Mendoza S; David H; Gaylord GM; Miller CW
    Cancer Genet Cytogenet; 2005 Apr; 158(2):142-7. PubMed ID: 15796961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional characterization of a novel FGFR2 mutation, E731K, in craniosynostosis.
    Park J; Park OJ; Yoon WJ; Kim HJ; Choi KY; Cho TJ; Ryoo HM
    J Cell Biochem; 2012 Feb; 113(2):457-64. PubMed ID: 21928350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel mutation in the tyrosine kinase domain of FGFR2 in a patient with Pfeiffer syndrome.
    Zankl A; Jaeger G; Bonafé L; Boltshauser E; Superti-Furga A
    Am J Med Genet A; 2004 Dec; 131(3):299-300. PubMed ID: 15523615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re: Sequence analysis of fibroblast growth factor receptor 2 (FGFR2) in Japanese patients with craniosynostosis. Sakai et al. J Craniofac. Surg. 2001, 12: 580-585.
    Warren SM; Longaker MT
    J Craniofac Surg; 2002 Jul; 13(4):597-9. PubMed ID: 12140430
    [No Abstract]   [Full Text] [Related]  

  • 39. Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Apert syndrome-like phenotypes.
    Yu K; Ornitz DM
    Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3641-3. PubMed ID: 11274381
    [No Abstract]   [Full Text] [Related]  

  • 40. The ups and downs of mutation frequencies during aging can account for the Apert syndrome paternal age effect.
    Yoon SR; Qin J; Glaser RL; Jabs EW; Wexler NS; Sokol R; Arnheim N; Calabrese P
    PLoS Genet; 2009 Jul; 5(7):e1000558. PubMed ID: 19593369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.